However, the company's financial results have been pretty strong. And if DexCom can keep that up in its next quarterly update ...

Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

The use of CGM has been growing among people without diabetes, including those with prediabetes, particularly with the ...

Continuous glucose monitors — the tiny sensors once reserved for people with diabetes — are now appearing on the arms of ...

Thank you, operator, and welcome to DexCom's Third Quarter 2025 Earnings Call. Our agenda begins with Jake Leach, DexCom's President and Interim CEO, who will summarize our recent highlights and ...

The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.

DexCom stock drops 15% despite strong Q3 and raised 2025 revenue outlook, as margin concerns and D7 product issues spark uncertainty for future growth. Read more here.

Spending more time in glucose range could help reduce adverse pregnancy outcomes, but available closed-loop insulin delivery systems are not customized to pregnancy-specific needs. In a randomized ...

Research shows that more daytime movement in pregnant women with hyperglycemia can raise nighttime blood sugar, highlighting ...

The global digital health market is set to witness a significant growth rate of 20-25% in the next 5 years. increasing adoption of smartphones and wearable devices, rising demand for remote healthcare ...

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the ...

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of DexCom, Inc. (NASDAQ: DXCM) s ...